Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$338M |
| 2 |
Visa
V
|
+$279M |
| 3 |
Microsoft
MSFT
|
+$277M |
| 4 |
Union Pacific
UNP
|
+$277M |
| 5 |
SIVB
SVB Financial Group
SIVB
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$440M |
| 2 |
Palo Alto Networks
PANW
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$281M |
| 4 |
Cognizant
CTSH
|
+$280M |
| 5 |
CrowdStrike
CRWD
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.5% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.23% |
| 4 | Industrials | 11.12% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Quantum-Si Incorporated
QSI
$179M
| $75.7K | ﹤0.01% |
41,369
-147
| -0.4% | -$379 |
|
3727
MarketWise
MKTW
$52.8M
| $74.8K | ﹤0.01% |
2,227
+1,599
| +255% | +$69.5K |
|
|
AFMD
3728
DELISTED
Affimed
AFMD
| $74.7K | ﹤0.01% |
6,027
+496
| +9% | +$8.7K |
|
|
NEUE
3729
DELISTED
NeueHealth
NEUE
| $74.7K | ﹤0.01% |
1,437
+591
| +70% | +$43K |
|
3730
EverCommerce
EVCM
$1.75B
| $74.7K | ﹤0.01% |
10,037
-121
| -1% | -$925 |
|
3731
NextDecade
NEXT
$1.8B
| $74K | ﹤0.01% |
14,979
-855
| -5% | -$4.91K |
|
|
NYC
3732
American Strategic Investment Co
NYC
$25.3M
| $73.9K | ﹤0.01% |
5,216
-26
| -0.5% | -$560 |
|
|
SOND
3733
DELISTED
Sonder
SOND
| $73.6K | ﹤0.01% |
2,969
-404
| -12% | -$14.3K |
|
|
AAIC
3734
DELISTED
Arlington Asset Investment Corp.
AAIC
| $73.3K | ﹤0.01% |
+25,031
| New | +$74K |
|
3735
MeiraGTx Holdings
MGTX
$1.21B
| $73.2K | ﹤0.01% |
11,227
-5
| -0% | -$34 |
|
|
TSP
3736
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $72K | ﹤0.01% |
43,912
-1,060,828
| -96% | -$3.78M |
|
|
XXII
3737
22nd Century Group
XXII
$1.52M
| – | – |
0
| – | – |
|
3738
Kaixin Holdings
KXIN
$8.43M
| $71.8K | ﹤0.01% |
1
| – | – |
|
3739
Rackspace Technology
RXT
$1.1B
| $71.6K | ﹤0.01% |
24,284
+439
| +2% | +$1.85K |
|
3740
Nkarta
NKTX
$167M
| $70.8K | ﹤0.01% |
+11,828
| New | +$119K |
|
3741
Village Farms International
VFF
$296M
| $70.8K | ﹤0.01% |
52,837
-270
| -0.5% | -$514 |
|
|
YMAB
3742
DELISTED
Y-mAbs Therapeutics
YMAB
| $70K | ﹤0.01% |
14,349
-2,454
| -15% | -$17.8K |
|
|
CMRX
3743
DELISTED
Chimerix, Inc.
CMRX
| $69K | ﹤0.01% |
37,096
+2,517
| +7% | +$4.92K |
|
|
SRTA
3744
Strata Critical Medical Inc
SRTA
$533M
| $68.3K | ﹤0.01% |
19,073
-2,283
| -11% | -$9.76K |
|
3745
Blend Labs
BLND
$341M
| $67.4K | ﹤0.01% |
46,815
| – | – |
|
|
EMKR
3746
DELISTED
Emcore Corp
EMKR
| $66.4K | ﹤0.01% |
6,899
-35
| -0.5% | -$500 |
|
|
GBIO
3747
DELISTED
Generation Bio
GBIO
| $65.6K | ﹤0.01% |
1,668
-2
| -0.1% | -$105 |
|
3748
Viant Technology
DSP
$264M
| $65.5K | ﹤0.01% |
+16,282
| New | +$65.6K |
|
3749
Bioventus
BVS
$1.16B
| $65K | ﹤0.01% |
24,896
+13,274
| +114% | +$58K |
|
3750
Precigen
PGEN
$2.46B
| $64.6K | ﹤0.01% |
42,517
-3,815
| -8% | -$6.56K |
|
Similar funds
Invesco's Q4 2022 Portfolio in Review
As of Q4 2022, Invesco held 4,129 positions worth $341B, up 9.9% from $311B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Invesco's Q4 2022 filing shows 147 new, 2,069 increased, 1,601 reduced and 115 closed positions. Its largest new stake was British American Tobacco: 3,556,143 shares worth $142M. The largest sale was UnitedHealth, an estimated $440M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q4 2022 buy was British American Tobacco: 3,556,143 shares worth $142M.
- Invesco added most to NVIDIA in Q4 2022, an estimated $338M increase.
- Invesco's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $440M.
- Invesco fully exited Duke Realty Corp. in Q4 2022, selling an estimated $131M.
- Invesco's ten largest holdings make up 10% of its $341B portfolio in Q4 2022.
- Invesco opened 147 new positions and closed 115 in Q4 2022.
- Invesco's portfolio value rose 9.9% quarter-over-quarter to $341B.
Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.